Once notorious for cheap knockoffs, India is assuming a mainstream role in the global drug industry thanks to stronger patent protections and cost pressures on name-brand drug makers in the West. "Manufacturing, packaging and formulation are moving to India," says an industry consultant, who arranges tours of Indian factories for Western pharma execs thinking of outsourcing. Article
Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes
Wednesday, March 24 | 2pm ET / 11am PT
Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.